CBRL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cracker Barrel Old Country Store Inc (CBRL) is not a strong buy at this time for a beginner investor with a long-term focus. The company's financial performance is weak, with significant YoY declines in revenue, net income, and EPS. Analysts' ratings and price targets suggest limited upside, and trading sentiment is neutral. While technical indicators show some positive momentum, there are no strong proprietary trading signals or significant catalysts to support a buy recommendation. Holding or exploring alternative investments may be more prudent.
The MACD histogram is positive at 0.175 and expanding, suggesting bullish momentum. RSI is neutral at 56.142, and moving averages are converging, indicating no clear trend. The current price is near the R1 resistance level of 29.922, with support at 28.749. Overall, technical indicators are mixed, with no strong buy signal.
Some analysts note improving trends in guest traffic and operational improvements. Early signs of recovery from the August rebranding issue are visible. Technical indicators show slight bullish momentum.
Weak financial performance in Q2 2026, with significant YoY declines in revenue (-7.86%), net income (-94.23%), and EPS (-93.94%). Analysts express concerns about limited balance-sheet flexibility and a protracted traffic recovery. Rising costs in the agricultural sector could pressure margins further.
In Q2 2026, revenue dropped to $874.8M (-7.86% YoY), net income fell to $1.28M (-94.23% YoY), and EPS declined to $0.06 (-93.94% YoY). Gross margin also decreased slightly to 66.55% (-1.22% YoY), reflecting significant financial challenges.
Analyst sentiment is mixed to negative. Freedom Broker initiated coverage with a Hold rating and a $30 price target. BofA raised the price target to $31 but maintained an Underperform rating. Truist is more optimistic with a Buy rating and a $47 price target, citing operational improvements. However, the majority of analysts remain cautious, with limited visibility into the pace of recovery.
